Clinical Trial Update: Vitiligo Treatment by Targeting TYK2 Mediated Responses [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a TYK2-targeted treatment for generalized vitiligo is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo Generalized

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Vitiligo, Generalized | Phase 2 | Status: RECRUITING